Authors: DEMANT EJF FRICHE E

Citation: Ejf. Demant et E. Friche, KINETICS OF ANTHRACYCLINE ACCUMULATION IN MULTIDRUG-RESISTANT TUMOR-CELLS - RELATIONSHIP TO DRUG LIPOPHILICITY AND SERUM-ALBUMIN BINDING, Biochemical pharmacology, 56(9), 1998, pp. 1209-1217

Authors: DEMANT EJF FRICHE E

Citation: Ejf. Demant et E. Friche, EQUILIBRIUM BINDING OF ANTHRACYCLINE CYTOSTATICS TO SERUM-ALBUMIN ANDSMALL UNILAMELLAR PHOSPHOLIPID-VESICLES AS MEASURED BY GEL-FILTRATION, Biochemical pharmacology, 55(1), 1998, pp. 27-32

Authors: DEMANT EJF

Citation: Ejf. Demant, COVALENT COMPLEXES BETWEEN SERUM-ALBUMIN AND 7-HYDROXYCOUMARIN-4-ACETIC ACID - SYNTHESIS AND APPLICATIONS IN THE SPECTROPHOTOMETRIC DETECTION OF LONG-CHAIN FATTY-ACIDS, Biochimica et biophysica acta, L. Lipids and lipid metabolism, 1304(1), 1996, pp. 43-55

Authors: JENSEN PB SORENSEN BS SEHESTED M GRUE P DEMANT EJF HANSEN HH

Citation: Pb. Jensen et al., TARGETING THE CYTOTOXICITY OF TOPOISOMERASE II-DIRECTED EPIPODOPHYLLOTOXINS TO TUMOR-CELLS IN ACIDIC ENVIRONMENTS, Cancer research, 54(11), 1994, pp. 2959-2963

Authors: SEHESTED M JENSEN PB SORENSEN BS HOLM B FRICHE E DEMANT EJF

Citation: M. Sehested et al., ANTAGONISTIC EFFECT OF THE CARDIOPROTECTOR (-1,2-BIS(3,5-DIOXOPIPERAZINYL-1-YL)PROPANE (ICRF-187) ON DNA BREAKS AND CYTOTOXICITY INDUCED BYTHE TOPOISOMERASE-II DIRECTED DRUGS DAUNORUBICIN AND ETOPOSIDE (VP-16)()), Biochemical pharmacology, 46(3), 1993, pp. 389-393

Authors: JENSEN PB SORENSEN BS SEHESTED M DEMANT EJF KJELDSEN E FRICHE E HANSEN HH

Citation: Pb. Jensen et al., DIFFERENT MODES OF ANTHRACYCLINE INTERACTION WITH TOPOISOMERASE-II-SEPARATE STRUCTURES CRITICAL FOR DNA-CLEAVAGE, AND FOR OVERCOMING TOPOISOMERASE-II-RELATED DRUG-RESISTANCE, Biochemical pharmacology, 45(10), 1993, pp. 2025-2035